
UK-CAB
@ukcab
HIV treatment advocates network: Supporting advocates in the UK | Providing expert training on treatment | Ensuring PLWHIV represented at all levels of our care
ID: 1221658778
https://linktr.ee/UKCAB 26-02-2013 13:14:52
2,2K Tweet
2,2K Followers
515 Following

18+, living in the UK and aware of #mpox (formerly #monkeypox)? Take part in this short, anonymous #StigmaSurvey, co-developed by community sexual health advocate Harun. The poxie one. and researchers at University of Oxford. No personal experience of mpox needed. bit.ly/mpoxstigma



For those attending #BHIVA24, please check out the poster on understanding participants perspectives around HIV cure-related research involving ATIs in UK, presented by Dr Godakandaarachchi Guy's and St Thomas'


Congratulations to our coordinator Memory Sachikonye on receiving her 'Unsung Hero Award' at #BHIVA24 🎉



We all make mistakes It is about the intention Language has an impact Harun. The poxie one. talking with caroline about people first language at the PeopleFirstCharter HIV Medicine session #BHIVA24



Hear from the wonderful women who attended our recent WISEUP on Bone Health & HIV for women, Education, Advocacy, Empowerment, Connection #PeerSupport 🙌🏽🥰❤️ Gilead Sciences Nneka Nwokolo BHIVA NAM Publications Dr Jacqui Stevenson UK-CAB


Great to see the landmark CARES Study published in The Lancet HIV Successful use of LA-CAB/RPV in a Public Health approach with sp much to unpick about DNA RAMs, VL monitoring & durability of response - incredible trial!! Ta for the heads up Nicola Mackie thelancet.com/journals/lanin…





i-Base calls on Gilead Sciences to agree to generic licences for amazingly effective #lenacapavir for #PrEP. Essential to ensure access in low- and middle-income countries: i-base.info/htb/47979 #HIV #HIVPrevent #SexualHealth #STIprevention #Purpose1 #SouthAfrica #Uganda


I'm at St John's Hospice | London with our fabulous peer support worker Fernando talking about HIV! An incredible institution (charitable of course, like so many organisations we rely on) & some incredible conversations with staff & service users ❤️❤️❤️❤️



🚨 Gilead Sciences lenacapavir could be a game-changer for #HIV -but at $28K/year, it’s priced out of reach for most. Generics could cost <$50. We’re calling on Gilead HIV to make it affordable for all, not just the privileged few. Please find UK-CAB public response below.


